1. Home
  2. PGY vs MLTX Comparison

PGY vs MLTX Comparison

Compare PGY & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pagaya Technologies Ltd.

PGY

Pagaya Technologies Ltd.

N/A

Current Price

$13.52

Market Cap

1.1B

Sector

Finance

ML Signal

N/A

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

N/A

Current Price

$11.08

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PGY
MLTX
Founded
2016
2021
Country
United States
Switzerland
Employees
503
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
PGY
MLTX
Price
$13.52
$11.08
Analyst Decision
Strong Buy
Buy
Analyst Count
11
16
Target Price
$29.45
★ $30.29
AVG Volume (30 Days)
★ 1.8M
1.5M
Earning Date
10-29-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 116.43
N/A
EPS
★ 1.30
N/A
Revenue
★ $1,301,360,000.00
N/A
Revenue This Year
$12.99
N/A
Revenue Next Year
$16.38
N/A
P/E Ratio
$11.25
★ N/A
Revenue Growth
★ 26.07
N/A
52 Week Low
$10.40
$9.46
52 Week High
$26.80
$23.29

Technical Indicators

Market Signals
Indicator
PGY
MLTX
Relative Strength Index (RSI) 27.93 44.69
Support Level $12.46 $10.67
Resistance Level $16.42 $13.64
Average True Range (ATR) 1.01 0.83
MACD -0.41 -0.12
Stochastic Oscillator 1.67 14.06

Price Performance

Historical Comparison
PGY
MLTX

About PGY Pagaya Technologies Ltd.

Pagaya Technologies Ltd is a product-focused technology company. It uses machine learning, a vast data network, and an AI-driven approach to offer comprehensive consumer credit and residential real estate products for its partners, their customers, and investors. Its suite of products includes Decline Monetization, Dual Look, First Look, Affiliate Optimizer Engine, Direct Marketing Engine, and FastPass, providing lenders with an AI-powered credit and acquisition ecosystem that helps them approve more borrowers, capture more demand, and grow without adding risk. Geographically, the company generates maximum revenue from its business in the United States.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Share on Social Networks: